公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1999 | Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years | SHANG-YI HUANG ; JIH-LUH TANG ; SHIANN-TANG JOU ; WOEI TSAY ; Hu C.-H.; DONG-TSAMN LIN ; Lin K.-S.; Lin K.-S.; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 13 | | |
2012 | Mycobacterial infections in adult patients with hematological malignancy | Chen, Chien-Yuan ; WANG-HUEI SHENG ; Lai C.-C.; Liao C.-H.; YU-TSUNG HUANG ; WOEI TSAY ; SHANG-YI HUANG ; JIH-LUH TANG ; HWEI-FANG TIEN ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 32 | 25 | |
2017 | A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan | SHANG-YI HUANG ; Yu Y.-B.; Yeh S.-P.; Chen T.-Y.; Kao W.-Y.; Chen C.-C.; Wang M.-C.; Lin H.-Y.; Lin S.-F.; Lin T.-H.; Hua Y.; Puccio-Pick M.; DeMarco D.; Jacques C.; Dunn P. | Journal of the Formosan Medical Association | 2 | 2 | |
2004 | Nonirradiated NOD/SCID-Human Chimeric Animal Model for Primary Human Multiple Myeloma: A Potential in Vivo Culture System | SHANG-YI HUANG ; HWEI-FANG TIEN ; Su F.-H.; Hsu S.-M. | American Journal of Pathology | 22 | 20 | |
2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos M.A.; Gay F.; Schjesvold F.; Beksac M.; Hajek R.; Weisel K.C.; Goldschmidt H.; Maisnar V.; Moreau P.; Min C.K.; Pluta A.; Chng W.-J.; Kaiser M.; Zweegman S.; Mateos M.-V.; Spencer A.; Iida S.; Morgan G.; Suryanarayan K.; Teng Z.; Skacel T.; Palumbo A.; Dash A.B.; Gupta N.; Labotka R.; Rajkumar S.V.; Bar D.; Basso A.; Fantl D.; He S.; Horvath N.; Lee C.; Rowlings P.; Taylor K.; Cochrane T.; Kwok F.; Ramanathan S.; Agis H.; Zojer N.; Kentos A.; Offner F.; Van Droogenbroeck J.; Wu K.L.; Maiolino A.; Martinez G.; Zanella K.; Capra M.; Araújo S.; Gregora E.; Pour L.; Scudla V.; Spicka I.; Abildgaard N.; Andersen N.; Jensen B.A.; Helleberg C.; Plesner T.; Salomo M.; Svirskaite A.; Delarue R.; Blau I.; Schieferdecker A.; Teleanu V.; Munder M.; Röllig C.; Salwender H.-J.; Fuhrmann S.; Weisel K.; Duerig J.; Zeis M.; Klein S.; Reimer P.; Schmidt C.; Scheid C.; Mayer K.; Hoffmann M.; Sosada M.; Dimopoulos A.; Delimpasi S.; Kyrtsonis M.-C.; Anagnostopoulos A.; Nagy Z.; Illés Á; Egyed M.; Borbényi Z.; Mikala G.; Dally N.; Horowitz N.; Gutwein O.; Nemets A.; Vaxman I.; Shvetz O.; Trestman S.; Ruchlemer R.; Nagler A.; Tadmor T.; Rouvio O.; Preis M.; Cavo M.; De Rosa L.; Musto P.; Cafro A.; Tosi P.; Offidani M.; Corso A.; Rossi G.; Liberati A.M.; Bosi A.; Suzuki K.; Nakaseko C.; Ishikawa T.; Matsumoto M.; Nagai H.; Sunami K.; Chou T.; Akashi K.; Takezako N.; Hagiwara S.; Eom H.S.; Jo D.-Y.; Kim J.S.; Lee J.H.; Yoon S.S.; Yoon D.H.; Kim K.; Levin M.-D.; Vellenga E.; Minnema M.; Waage A.; Haukås E.; Grosicki S.; Pluta A.; Robak T.; Marques H.; Bergantim R.; Campilho F.; Chng W.J.; Goh Y.T.; McDonald A.; Rapoport B.; Álvarez Rivas M.A.; De Arriba de La Fuente F.; González Montes Y.; Martin Sanchez J.; Mateos M.V.; Oriol Rocafiguera A.; Rosinol L.; San Miguel J.; Pérez de Oteyza J.; Encinas C.; Alegre-Amor A.; López-Guía A.; Axelsson P.; Carlson K.; Stromberg O.; Hansson M.; Hveding Blimark C.; Mueller R.; Chen C.-C.; Liu T.-C.; SHANG-YI HUANG ; Wang P.-N.; Na Nakorn T.; Prayongratana K.; Unal A.; Goker H.; Sonmez M.; Korenkova S.; Chaidos A.; Oakervee H.; Sati H.; Benjamin R.; Wechalekar A.; Garg M.; Ramasamy K.; Cook G.; Chantry A.; Jenner M.; Buadi F.; Berryman R.; Janakiram M.; TOURMALINE-MM3 study group | The Lancet | 181 | 167 | |
2014 | The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy | Lin H.-H.; Hwang S.-M.; SHANG-JU WU ; Hsu L.-F.; YI-HUA LIAO ; YI-SHUAN SHEEN ; Chuang W.-H.; SHANG-YI HUANG | PLoS ONE | 10 | 8 | |
2019 | Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials | Dimopoulos M.A.; Moreau P.; Iida S.; SHANG-YI HUANG ; Takezako N.; Chng W.J.; Zahlten-Kumeli A.; Sersch M.A.; Li J.; Huang M.; Lee J.H. | International Journal of Hematology | 11 | 11 | |
2018 | Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma | SHANG-YI HUANG ; Chang C.-S.; Liu T.-C.; Wang P.-N.; Yeh S.-P.; Ho C.-L.; Kuo M.-C.; Lin H.-Y.; de Jong J.; Chen J.-Y.; Yang Y.-W. | Hematological Oncology | 1 | 2 | |
2017 | Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma | Raje N.S.; Moreau P.; Terpos E.; Benboubker L.; Grząśko N.; Holstein S.A.; Oriol A.; SHANG-YI HUANG ; Beksac M.; Kuliczkowski K.; Tai D.F.; Wooldridge J.E.; Conti I.; Kaiser C.J.; Nguyen T.S.; Cronier D.M.; Palumbo A. | British Journal of Haematology | 38 | 33 | |
2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |
2019 | Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network | Soekojo C.Y.; Kim K.; SHANG-YI HUANG ; Chim C.-S.; Takezako N.; Asaoku H.; Kimura H.; Kosugi H.; Sakamoto J.; Gopalakrishnan S.K.; Nagarajan C.; Wei Y.; Moorakonda R.; Lee S.L.; Lee J.J.; Yoon S.-S.; Kim J.S.; Min C.K.; Lee J.-H.; Durie B.; Chng W.J. | Blood Cancer Journal | 12 | 7 | |
2010 | Primary biliary cirrhosis associated with pernicious anemia | Chung C.-S.; Hsu Y.-C.; SHANG-YI HUANG ; YUNG-MING JENG ; CHIEN-HUNG CHEN | Canadian Family Physician | 6 | 5 | |
2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
2017 | Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Liu, Chieh-Yu; Tseng, Mei-Hsuan; Lin, Tzung-Yi; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin, Chien-Ting; SHANG-JU WU ; Chen, Chien-Yuan ; WOEI TSAY ; ERIC YAO-YU CHUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 35 | 33 | |
2014 | Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations | SHENG-CHIEH CHOU ; JIH-LUH TANG ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Hu F.-C.; Chen, Chien-Yuan ; MING YAO ; BOR-SHENG KO ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia Research | 18 | 18 | |
2019 | Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma | Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG ; D'Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. | Annals of Hematology | 38 | 33 | |
2018 | Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop | Tan D.; Lee J.H.; Chen W.; Shimizu K.; Hou J.; Suzuki K.; Nawarawong W.; SHANG-YI HUANG ; Sang Chim C.; Kim K.; Kumar L.; Malhotra P.; Chng W.J.; Durie B.; for the Asian Myeloma Network | Leukemia and Lymphoma | 16 | 13 | |
2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
2015 | Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults | Chieh-Lung Cheng ; Li, Chi-Cheng; HSIN-AN HOU ; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; JIH-LUH TANG ; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | BMC cancer | 42 | 40 | |